Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r
Slim Fourati, Christophe Rodriguez, Christophe Hézode, Alexandre Soulier, Isaac Ruiz, Lila Poiteau, Stéphane Chevaliez, Jean‐Michel Pawlotsky – 19 August 2018 – Hepatitis C virus (HCV) genotype 4 is highly heterogeneous. HCV subtype 4r has been suggested to be less responsive to direct‐acting antiviral (DAA) drug treatment than other genotype 4 subtypes.